Ixia Stock Falls On Unusually High Volume (XXIA)

NEW YORK ( TheStreet) -- Ixia (Nasdaq: XXIA) is trading at unusually high volume Monday with 1.5 million shares changing hands. It is currently at four times its average daily volume and trading down 24 cents (-2.4%) at $9.66 as of 2:52 p.m. ET.

Ixia has a market cap of $893.8 million and is part of the technology sector and electronics industry. Shares are down 41% year to date as of the close of trading on Friday.

Ixia supplies converged network and application performance testing solutions for network equipment manufacturers, service providers, enterprises, and government agencies the United States and internationally. It designs and validates a range of IP and 3G/LTE networking equipment. The company has a P/E ratio of 50, below the average electronics industry P/E ratio of 52 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Ixia as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall. You can view the full Ixia Ratings Report.

See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.

Interested in other stocks that are falling on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting HVDOWN to 95370 or select from multiple alert options.

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing